Latest News

Last week, you might have seen that VBG Group AB (publ) ( STO:VBG B ) released its second-quarter result to the market...

It's been a good week for Bilia AB (publ) ( STO:BILI A ) shareholders, because the company has just released its latest...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

It's been a sad week for Lindab International AB (publ) ( STO:LIAB ), who've watched their investment drop 11% to kr120...

Amidst a backdrop of global market fluctuations and geopolitical tensions, Asian stock markets have faced their share of challenges recently, with notable declines in technology sectors impacting major indices. However, this environment can present opportunities for investors to explore stocks that may be trading below their estimated value. Identifying such undervalued stocks often involves looking at companies with strong fundamentals that might be temporarily overlooked due to broader...

As Asian markets navigate a landscape of fluctuating technology stocks and geopolitical tensions, investors are increasingly exploring diverse opportunities. Penny stocks, despite their somewhat outdated moniker, remain an intriguing investment area for those seeking value in smaller or newer companies. These stocks can offer surprising potential when backed by solid financials, making them noteworthy contenders for investors looking to uncover under-the-radar opportunities with promising...

As Asian markets navigate a landscape marked by volatile tech stocks and geopolitical tensions, small-cap indices like the S&P 600 have shown resilience amid broader market fluctuations. With inflation cooling and rate-hike odds dropping, investors are increasingly on the lookout for hidden gems that can offer growth potential in this dynamic environment. Identifying promising stocks requires a keen eye for companies with robust fundamentals and unique market positions that can thrive despite...

Amid a backdrop of volatility in global markets, Asian equities have shown resilience, with certain sectors experiencing notable growth despite broader economic challenges. In this environment, companies with high insider ownership often stand out as potential opportunities due to the alignment of interests between management and shareholders.

Amidst a backdrop of volatility in global markets, Asian equities have shown resilience, with some sectors experiencing notable fluctuations due to geopolitical tensions and shifts in technology valuations. As investors navigate these uncertain waters, dividend stocks offer a potential avenue for steady income, making them an attractive consideration for those seeking stability and consistent returns amidst market unpredictability.

Last week, you might have seen that DKSH Holding AG ( VTX:DKSH ) released its half-yearly result to the market. The...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Geratherm...

Artificial intelligence is sitting at the center of market attention, as energy driven inflation risks, tight central bank policy and shifting trade patterns keep pressure on traditional growth stories. While oil prices, bond yields and tariff headlines move daily, AI related spending on chips, software, cloud and large language models is still a key focus for many companies and investors. This article uses an AI Stocks screener that targets businesses directly tied to the ChatGPT and broader...

Markets are being pulled in different directions right now, with a tech-driven rally on one side and rising geopolitical and supply chain risks on the other. For income focused investors, that can sharpen interest in companies with steady dividends and solid balance sheets, especially when Fed policy expectations are relatively stable and attention is shifting to high conviction areas. This article looks at how today’s mix of semiconductor strength, Middle East tensions and macro uncertainty...

Walliser Kantonalbank (SWX:WKBN) has reported its H1 2026 results with trailing 12 month revenue of CHF 276.4 million and net income of CHF 88.5 million, setting the stage against a backdrop where the net profit margin over the last year stood at 32% compared with 45% in the prior period. Over recent halves, the bank has seen revenue move from CHF 154.1 million in H2 2024 to CHF 135.7 million in H2 2025, alongside net income shifting from CHF 69.4 million to CHF 24.9 million. This leaves...

Sandvik (OM:SAND) is in focus after reporting second quarter 2026 results, with sales of SEK 36,752 million and net income of SEK 5,236 million, alongside higher basic earnings per share year on year. See our latest analysis for Sandvik. Despite the strong second quarter figures, Sandvik’s share price of SEK346.9 is down 14.7% on a 30 day basis and 11.6% over 90 days, while its 1 year total shareholder return of 48.9% points to stronger longer term momentum. If Sandvik’s latest move has you...

Embla Medical hf (CPSE:EMBLA) has put up a solid Q2 2026 print, with revenue of US$258.6 million and basic EPS of US$0.069, building on a trailing twelve month profile that includes US$984.5 million in revenue, US$93.9 million in net income excluding extra items and basic EPS of about US$0.219. Over the past six reported quarters, the company has seen revenue move from US$202.8 million in Q1 2025 to US$258.6 million in Q2 2026, while quarterly basic EPS has ranged between US$0.028 and...

Delek Logistics Partners stock has delivered strong returns over the past several years, yet the current market pricing screens as expensive on key valuation checks, leaving investors weighing a solid track record against a relatively full valuation. Over the last 5 years, Delek Logistics Partners has returned 113.2%, which puts more pressure on today’s buyers to justify the higher entry price. Future cash flow resilience and the partnership’s ability to fund its capital needs efficiently...

Andersons stock has delivered a very strong 226.3% total return over the past five years, yet the current valuation checks point to a mixed picture rather than a clear bargain or clear overvaluation at the recent price of US$77.85. A 226.3% return over five years indicates that long term holders in Andersons have been strongly rewarded, which raises the bar for new buyers assessing what is already priced in. For Andersons, the key support for valuation is whether the business can keep...

Valmont Industries (VMI) has reported another solid quarter, with Q2 2026 revenue of US$1.1 billion and basic EPS of US$6.19 supported by net income of US$119.9 million, set against trailing 12 month EPS of US$24.54 on revenue of US$4.2 billion. The company’s revenue increased from US$1.0 billion in Q1 2026 to US$1.1 billion in Q2 2026, while basic EPS rose from US$5.55 over the same period. This gives investors a fresh look at how recent earnings momentum is feeding into margins. See our...

Why KB801’s Patent Filing Matters For Krystal Biotech Stock Krystal Biotech (KRYS) recently filed a response with the U.S. Patent and Trademark Office for KB801, sharing previously undisclosed single patient data on corneal defect closure from a discontinued neurotrophic keratitis study. The company stressed that this observation comes from one patient and is not a substitute for clinical trial results. However, the disclosure offers investors a clearer view of how KB801 is progressing toward...

DHT Holdings recently secured a three-year time charter for one of its very large crude carriers with commodities major Glencore, underscoring sustained demand for its VLCC capacity in the period market. This long-duration contract not only supports operational planning and fleet employment but also enhances visibility on vessel utilization and forward revenue for the tanker owner. We’ll now examine how this multi-year Glencore VLCC charter interacts with DHT’s existing investment narrative...

Arteris (AIP) is back in focus after announcing an expanded partnership with Arm that embeds its Cycuity Radix hardware security tools more deeply into Arm’s next-generation CPU development flow. See our latest analysis for Arteris. The Arm partnership news comes after a sharp 11.54% 1 day share price return, even though the 30 day share price return is down 22.42%. At the same time, the 1 year total shareholder return of 262.50% and 3 year total shareholder return of about 3.7x highlight how...

Tariffs on imported generic drugs are set to rise sharply over the next few years, and that kind of policy shock rarely stays contained to one corner of the market. For investors, the question is which U.S. pharmaceutical and biotech manufacturing stocks might stand to benefit if production shifts closer to home, and which could face new pressures through supply chain or pricing risks. This article looks at how the new tariff path could affect larger domestic drug manufacturers and contract...

Criteo (NasdaqGS:CRTO) has drawn fresh investor attention after its recent share performance, with the stock up about 24% over the past month and roughly 11% over the past 3 months. See our latest analysis for Criteo. Despite the recent 23.68% 1 month share price return and 11.36% 3 month share price return, Criteo’s longer term picture is more mixed, with the 1 year total shareholder return declining 7.07%. This suggests improving near term momentum following weaker multi year...